RA Capital Management, LLC, 10% Owner at BIOSPECIFICS TECHNOLOGIES CORP (BSTC), bought 11,900 shares at $15.00 ($172K) on 2008-11-03, disclosed to the SEC on 2008-11-04.
Open-market purchase of $172k BSTC by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.00 | 1,000 | $14K | 8.1% |
| 2 | $13.50 | 5,020 | $68K | 39.3% |
| 3 | $14.00 | 200 | $3K | 1.6% |
| 4 | $14.50 | 600 | $9K | 5.1% |
| 5 | $15.00 | 400 | $6K | 3.5% |
| 6 | $15.50 | 3,000 |
| $47K |
| 27.0% |
| 7 | $16.00 | 200 | $3K | 1.9% |
| 8 | $16.50 | 580 | $10K | 5.6% |
| 9 | $15.00 | 700 | $11K | 6.1% |
| 10 | $16.00 | 200 | $3K | 1.9% |
| Total | $14.47 avg | 11,900 | $172K | 100% |
| Filing → |
| KALA | BUY | 2018-10-05 | $40.0M | — | Filing → |
| ARVN | BUY | 2018-10-03 | $16.0M | — | Filing → |
| WVE | BUY | 2017-11-15 | $9.9M | — | Filing → |